Skip to main content

Table 2 Schedule of events

From: Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant Irritable Bowel Syndrome: a double blind randomized placebo controlled pilot clinical study

Procedures

Screening

Visit 1

Visit 2

Visit 3

Visit 4

Follow up

(Day 0) Baseline

(Day 30)

(Day 60)

(Day 90) Final visit

(Atleast 15 days from last visit)

Informed consent

X

     

Medical history

X

     

Physical examination

X

X

X

X

X

 

Demographicsa

 

X

X

X

X

 

Vital signsb

X

X

X

X

X

 

Hematology

X

   

X

 

Serum chemistry

X

   

X

 

Stool test for consistency

X

   

X

 

Urine pregnancy testc

X

     

Randomization

 

X

    

IP dispensing and dosing

 

X

X

X

  

VAS assessment

 

X

X

X

X

 

Gastrointestinal discomfort questionnaire

 

X

X

X

X

 

Bristol stool score

 

X

X

X

X

 

Physician’s global assessment

 

X

X

X

  

Irritable bowel syndrome (IBS) quality of life questionnaire

 

X

X

X

X

 

Adverse events (AEs)

 

X

X

X

X

X

Concomitant medications

 

X

X

X

X

X

  1. aAge, gender, height, weight and BMI
  2. bVitals – pulse, temperature, blood pressure, heart rate, respiratory rate
  3. cUrine pregnancy test at screening and on early termination